News

Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer’s disease

Congratulations to:

for publishing a new article in European Journal of Medicinal Chemistry using our actimeters.

  • a Normandie Université, UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie), F-14032, Caen, France
  • b Normandie Université, UNICAEN, GMPc (Groupe Mémoire et Plasticité comportementale), F-14032, Caen, France